Category: The Arcus Vision
A Peek Into the Platform: How an Innovative Trial Design Can Accelerate Drug Development
To evaluate the growing number of treatment options for cancer efficiently and rigorously, we need to rethink the way we approach early clinical trials.
What Biotech Companies Can Learn from Consumer Tech Outliers
Patients are waiting, so life sciences companies must embrace change and evolve their thinking.
How do Biotechs Stay the Course in Uncharted Waters?
In the latest Beyond Borders: Ernst & Young’s biotechnology report 2022, Arcus Biosciences CEO Terry Rosen discusses the strategic partnership that put the company in a strong financial position to thrive during the turbulent market facing the biotech industry in 2022 and beyond.
Combining to Cure: Arcus Founders Talk Strategy and Legacy
There are many examples of productive relationships in science and research. Think of James Watson and Francis Crick, or Marie and Pierre Curie.
